A Journey of Resilience: Marcus’ Fight Against Rare GRIN2A Disorder (Part I)

At LDA Research, we know that behind every data point is a real person, a real family, and a real story.

We’re sharing one of those stories from Mariah from Minnesota, USA. It’s a story about her, her son and navigating a rare disease diagnosis, the challenges of accessing specialized care, and what she’s learned about the patient and caregiver experience from the inside.

Read part 1 of her story below.

A Journey of Resilience: Marcus’ Fight Against Rare GRIN2A Disorder

Marcus (2 years old) is bright, joyful, full of curiosity, and the kind of child who lights up every room. Until earlier this year (2025), he was meeting all his milestones, often ahead of schedule, walking, talking, thriving.

Then, everything changed.

We began noticing in March 2025 that Marcus was regressing – quickly – in his speech, motor skills, and overall development. Eventually, he became nonverbal. At first, we suspected a hearing issue, but multiple ENT visits ruled that out. It wasn’t until we shared a concerning video with his pediatrician that we were urgently referred to the ER for an inpatient neurology workup.

That hospital stay revealed abnormal brain activity consistent with seizures. He started on medication, but the side effects were severe and unmanageable. Since then, he’s tried three different medications, none of which have been effective, and some have made things worse. His seizures have since become more frequent and intense, leading to another hospitalization.

During that second hospital stay, we began the process of genetic testing. A few months later, we received a diagnosis that has completely changed our world: Marcus has GRIN2A and because GRIN2A is so rare, most doctors have limited knowledge of how to treat it.

Since the diagnosis, our lives have revolved around managing Marcus’s care. We’ve had to take on the roles of advocates, researchers and case managers, often without clear guidance or support. We’re now traveling out of state to specialists in Colorado and Pennsylvania just to access doctors who have experience with GRIN2A. The emotional toll is immense.

Marcus’s older brother has stepped into a quiet, protective role, one we never asked him to take on, but one he carries with grace. This journey affects our whole family, and we try to make space for everyone’s emotions, needs, and growth.

This is not a story about pity. It’s about resilience. About showing up every day in the face of the unknown. Marcus is not defined by his diagnosis, it’s just one part of his beautiful, unfolding story. He continues to teach us how to slow down, listen differently, and celebrate every small victory.

Though we’re the ones sharing our story, this is Marcus’s journey. Our job is to walk beside him to advocate fiercely, love unconditionally, and do everything we can to create a life filled with joy, dignity, and possibility.

We know we’re not the only family facing something like this. And by sharing what we’re going through, we hope others walking similar paths feel a little less alone.

Marcus’s Superpowers: His Light, His Connection, and His Extraordinary Strength

Marcus’ superpowers are his ability to connect and his light.

Even without words, Marcus has such a powerful way of reaching and teaching people through a silly look he gives, or when he smiles to show off his deep dimples, he truly has a presence that makes you pause and feel. He reminds people around him to slow down, to really listen, smell the flowers, and to see the world with more compassion and care. That’s not something you can teach someone; that’s something you feel in your bones when you’re near him.

He has the kind of strength and resilience that most people never have to develop. But Marcus lives it every single day and that makes him truly an extraordinary, rare superhero.

Share:

Facebook
X
LinkedIn
WhatsApp

More Blogs from LDA

The Power of Networks: Why Rare Diseases Demand Collaboration

Senior moderator Leigh Hart explores the role of pharmaceutical companies in the Rare Disease Networks, what was planned and how it has worked out. Rare diseases are far from rare. An estimated 300 to 400 million people live with one, yet their needs are often invisible to health systems, researchers, and the medical sciences industry. These conditions aren’t just “rare”

Continue reading »

Can AI replace human interaction in market research?

Senior Moderator Andrew Grant explores the capabilities and limitations of AI in qualitative research, sharing first hand insights from an experiment using Google Gemini to conduct an interview. This week, I’ve been trying to replace myself with AI.  In 2023, a Goldman Sachs report (https://www.bbc.co.uk/news/technology-65102150) estimated that AI would supplant up to 300 million jobs worldwide in the next few

Continue reading »

A Call to Action for Inclusive Research

This Chronic Disease Awareness Day patient advocate Roxanne Murray strives to ensure no one is left unseen or unheard in the MS, chronic illness and disability community The Invisibility of MS: What You Don’t See Still Deserves Support As I approach my 19th year of living with Multiple Sclerosis, I’ve come to understand just how misunderstood this condition can be.

Continue reading »

Contact us

Mandatory fields *